Spero Therapeutics, Inc. (NASDAQ:SPRO) Q3 2023 Earnings Call Transcript

Ted Jenkins: Thank you, operator, and thank you all for participating in today's conference call.

Related Keywords

Japan ,Oregon ,United States ,Canada ,Canadian ,Kevin Winthrop ,Sath Shukla ,Patrick Vink ,Milind Deshpande ,Ted Jenkins ,Steve Dipalma ,Esther Rajavelu ,Boobalan Pachaiyappan ,Ankit Mahadevia ,Kamal Hamed ,Louise Chen ,Science University ,Smartpros Ltd ,Xavier Life Tech Corporation ,Nasdaq ,Spero Therapeutics Inc ,Oregon Health ,Cantor Fitzgerald ,Spero Therapeutics ,Call Transcript November ,Spero Therapeutic ,Chief Executive Officer ,Chief Medical Officer ,Chief Financial Officer ,Chief Business ,Special Protocol Assessment ,Chief Business Officer ,Wall Street ,Expert Review ,License Agreement ,Xavier Life Tech ,Canadian Gold Stocks To Buy Now ,Billionaires In The ,